id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-3855-0007,FDA,FDA-2015-E-3855,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2019-07-03T04:00:00Z,2019,7,2019-07-03T04:00:00Z,,2019-07-03T15:34:32Z,,0,0,0900006483d5c52f
FDA-2015-E-3855-0006,FDA,FDA-2015-E-3855,"Determination of Regulatory Review Period for Purposes of Patent
Extension; BLINCYTO",Notice,Determinations,2018-02-07T05:00:00Z,2018,2,2018-02-07T05:00:00Z,2018-04-10T03:59:59Z,2018-02-08T02:02:26Z,2018-02419,0,0,0900006482ef6d11
FDA-2015-E-3855-0005,FDA,FDA-2015-E-3855,Letter from CDER to U.S. Patent and Trademark Office,Other,Letter(s),2017-05-12T04:00:00Z,2017,5,2017-05-12T04:00:00Z,,2017-05-12T18:13:54Z,,0,0,09000064825adc5d
FDA-2015-E-3855-0004,FDA,FDA-2015-E-3855,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:07:22Z,,0,0,0900006482433cb7
FDA-2015-E-3855-0003,FDA,FDA-2015-E-3855,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-11-02T05:00:00Z,2015,11,2015-11-02T05:00:00Z,,2015-11-02T15:23:53Z,,0,0,0900006481cfec81
FDA-2015-E-3855-0001,FDA,FDA-2015-E-3855,"Patent Extension Application from Marshall, Gerstein & Borun, LLP (on behalf of  Amgen Research (Munich) GMBH)",Other,Application,2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T20:30:51Z,,0,0,0900006481cdab45
FDA-2015-E-3855-0002,FDA,FDA-2015-E-3855,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-10-20T04:00:00Z,2015,10,2015-10-20T04:00:00Z,,2015-10-20T20:31:00Z,,0,0,0900006481cdab46